EP64: The Science for Womxn in Their Prime with Michele Wispelwey

Period To Pause

Michele Wispelwey joins Amanda in navigating the innovations in the femtech industry and the optimal healthcare measures for womxn’s menopausal care.

1. Considerable adjustments required to alleviate the outdated healthcare options for womxn

2. The significance of addressing feminine longevity, menopausal and perimenopausal care

3. FemGevity: How to access its personalized healthcare plans, longevity medicine, and other perks you can get

4. The next big thing to expect in the FemTech industry

5. Workplace interventions to manage menopausal womxn’s health and wellbeing

About Michele Wispelwey

Michele is the Director Of Women’s Health Services, specializing in molecular diagnostics, genetics, and cytology. With a background in top-ranked institutions such as Labcorp & Quest Diagnostics, she is recognized as a resourceful strategist, collaborating with healthcare leaders to improve patient access and update processes. Michele founded FemGevity, a digital telemedicine platform for menopause and feminine longevity, leveraging 18 years of experience in women's health initiatives. Her mission is to empower women through innovative solutions. Michele has worked with healthcare organizations and collaborated with renowned physicians to create actionable solutions. She actively participates in industry forums and events to foster collaboration and gain insights from like-minded leaders. Michele holds an MBA in healthcare management and marketing and a BS in Business Administration. With a passion for travel and art, she aims to fuse creativity and technology in women's healthcare.

Connect with Michele

• Website: FemGevity
• LinkedIn: FemGevity | Michele Wispelwey, MBA
• Facebook: femgevity
• Instagram: @femgevity
• TikTok: @femgevity

Support the show!

Want to learn more about us? Visit our website at www.periodtopause.com or send an email to [e-mail]

Follow us on Instagram: @periodtopause

Follow our Facebook Page: Period to Pause